Checkpoint Therapeutics Files 8-K
| Field | Detail |
|---|---|
| Company | Checkpoint Therapeutics, Inc. |
| Form Type | 8-K |
| Filed Date | Apr 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, filing, financials
Related Tickers: CKPT
TL;DR
Checkpoint Therapeutics (CKPT) filed an 8-K on 4/14/25 for a material definitive agreement.
AI Summary
On April 14, 2025, Checkpoint Therapeutics, Inc. filed an 8-K report. The filing indicates an entry into a material definitive agreement and includes financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located at 95 Sawyer Road, Suite 110, Waltham, MA 02453.
Why It Matters
This 8-K filing signals a significant event for Checkpoint Therapeutics, Inc., potentially involving a new material agreement that could impact its business operations and financial standing.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting a material definitive agreement and financial statements, without immediate indication of significant financial distress or major operational changes.
Key Players & Entities
- Checkpoint Therapeutics, Inc. (company) — Registrant
- April 14, 2025 (date) — Date of earliest event reported
- 95 Sawyer Road, Suite 110, Waltham, MA 02453 (location) — Address of principal executive offices
- Delaware (jurisdiction) — State of Incorporation
FAQ
What is the nature of the material definitive agreement filed by Checkpoint Therapeutics, Inc.?
The filing indicates an 'Entry into a Material Definitive Agreement' as an item of disclosure, but the specific details of the agreement are not provided in the excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on April 14, 2025.
Where are Checkpoint Therapeutics, Inc.'s principal executive offices located?
The principal executive offices are located at 95 Sawyer Road, Suite 110, Waltham, MA 02453.
Under which act was this 8-K filed?
This 8-K was filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the SIC code for Checkpoint Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Checkpoint Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 15, 2025 regarding Checkpoint Therapeutics, Inc..